Complimentary Webinar: Organic and Food Fraud: Ensuring Strengthening Organic Enforcement (SOE) Compliance
Date: April 25, 2024 | Time: 11:30 AM - 12:30 PM EDT
NORTHAMPTON, MA / ACCESSWIRE / April 17, 2024 / Are you ready for the new Organic program requirements? Join SCS Global Services for this informative webinar on the latest updates to the NOP and learn how to develop an Organic Fraud Prevention Plan (OFPP). Denise Webster, SCS' VP of Food Safety, and Brandon Nauman, SCS' Technical Director of Organic Program will explore how to conduct a Vulnerability Assessment to understand the risk factors within your supply chain. Additionally, we will discuss the elements of developing controls and monitoring to mitigate or eliminate food fraud risks identified.
By registering, you will get access to the webinar recording.
For inquiries, please contact:
Shyama Devarajan
Senior Marketing Manager, SCS Global Services
sdevarajan@scsglobalservices.com
View additional multimedia and more ESG storytelling from SCS Global Services on 3blmedia.com.
Contact Info:
Spokesperson: SCS Global Services
Website: https://www.3blmedia.com/profiles/scs-global-services
Email: info@3blmedia.com
SOURCE: SCS Global Services
View the original press release on accesswire.com
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track